CUAMC
ADIL

China Universal Asset Management Company’s Adial Pharmaceuticals ADIL Stock Holding History

China Universal Asset Management Company’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$20.5K Buy
+8,000
New +$15.8K ﹤0.01% 495

Other funds holding ADIL

RWML
RAFFA WEALTH MANAGEMENT, LLC Washington, District of Columbia $793M AUM 13.11% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return
AWM
Abound Wealth Management Franklin, Tennessee $504M AUM 23.73% 1-Year Est. Return

China Universal Asset Management Company's ADIL Position: Q2 2026 in Review

China Universal Asset Management Company opened a new position in Adial Pharmaceuticals (ADIL) in Q2 2026: 8,000 shares worth $20.5K. The stake represents ﹤0.01% of the portfolio and ranks #495 among its holdings.

4 funds tracked by Wall St. Rank hold ADIL as of Q2 2026.

  • China Universal Asset Management Company held 8,000 shares of Adial Pharmaceuticals worth $20.5K as of Q2 2026.
  • Adial Pharmaceuticals was a new China Universal Asset Management Company position in Q2 2026.
  • Adial Pharmaceuticals made up ﹤0.01% of China Universal Asset Management Company's portfolio in Q2 2026, its #495 holding.
  • 4 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q2 2026.

Based on China Universal Asset Management Company's 13F filing for Q2 2026, filed 24 Jul 2026.